The Targeted Drug Delivery Market Is Estimated To Be Valued At US$ 761.95 Mn In 2023 And Is Expected To Exhibit A CAGR Of 15% Over The Forecast Period 2023 To 2030, As Highlighted In A New Report Published By Coherent Market Insights.
Market Overview:
Targeted Drug Delivery Aims To Increase Therapeutic Efficacy Of Drugs By Directing Them To Specific Diseased Sites In The Body. It Involves Administration Of Drugs Encapsulated In Nanoparticles, Liposomes, Micelles Or Conjugated To Targeting Ligands Such As Antibodies. This Allows Targeted Release Of Drugs At Desired Locations Thereby Reducing Side Effects And Improving Patient Outcomes.
Market Dynamics:
Growth Of The Targeted Drug Delivery Market Is Primarily Driven By Rising Preference For Personalized Medicine Due To Increasing Focus On Individualized Treatment Approach. This Has Spurred Research On Targeted Drug Delivery Systems To Deliver Right Drug, In Right Form, In Right Place, In Right Time And In Right Amount. Secondly, Increased R&D In Nanomedicine And Development Of Nanoparticles, Dendrimers And Other Nanocarriers Has Improved Targeting Efficiency Of Drugs To Specific Sites Thereby Accelerating Market Growth Over The Forecast Period. However, High Costs Associated With Development Of Targeted Drug Delivery Systems Act As A Major Constraint For Market Growth.
SWOT Analysis
Strength: The Targeted Drug Delivery Market Offers Reduced Side Effects, Improved Therapeutic Efficacy, And Enhanced Patient Compliance. It Allows Targeted Delivery Of Drugs To Specific Organs, Tissues Or Tumor Cells. The Technology Helps Increase Drug Bioavailability And Utilization.
Weakness: High Costs Associated With R&D, Clinical Trials And Production Of Targeted Drug Delivery Systems Hamper Market Growth. Complex Manufacturing Processes Pose Challenges, Especially For Smaller Companies.
Opportunity: Rising Trend Of Personalized Medicine Provides Growth Opportunities. Increasing Demand For Non-Invasive And Site-Specific Drug Delivery Methods Will Drive The Market During The Forecast Period.
Threats: Stringent Regulatory Procedures For Approval Delay Product Launches. Safety Issues And Failure During Clinical Trials Threaten Market Revenue.
Key Takeaways:
The Global Targeted Drug Delivery Market Is Expected To Witness High Growth, Exhibiting A CAGR Of 15.% Over The Forecast Period, Due To Increasing Prevalence Of Chronic Diseases Such As Cancer And Respiratory Diseases. Targeted Drug Delivery Enables Localized And Site-Specific Treatment Of Diseases Which Supports The Market Growth.
Regional Analysis: North America Accounted For The Largest Share In The Global Targeted Drug Delivery Market In 2023. This Is Attributed To Increasing Healthcare Spending, Rising Cancer Incidence And Growing Adoption Of Advanced Therapies In The Region. Asia Pacific Exhibits The Fastest Growth Rate Over The Forecast Period Due To Rising Healthcare Awareness, Improving Healthcare Infrastructure And Increasing Disposable Incomes In Emerging Countries Such As India And China.
Key Players: Key Players Operating In The Targeted Drug Delivery Market Include Abbvie Inc., Ablynx NV By Sanofi SA, Arrowhead Pharmaceuticals, Inc., Baxter International Inc., Astrazeneca PLC, Boston Scientific Corporation, Becton, Depomed, Inc., Fraunhofer Gesellschaft Munchen, Janssen Global Services, LLC., Luye Pharma Group, Pfizer Inc., Quark Pharmaceuticals Inc., Rexahn Pharmaceuticals Inc., Savara Inc., Roche Holding AG, Suda Limited, Vectura Group PLC, Taiwan Liposome Company, Ltd., And 3M Company.
*Note:
1. Source: Coherent Market Insights, Public sources, Desk research
2. We have leveraged AI tools to mine information and compile it
Ravina Pandya, Content Writer, has a strong foothold in the market research industry. She specializes in writing well-researched articles from different industries, including food and beverages, information and technology, healthcare, chemical and materials, etc. With an MBA in E-commerce, she has an expertise in SEO-optimized content that resonates with industry professionals.